1 Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a standard class of medications that are used to treat type 2 diabetes mellitus (T2DM) (Collins and Costello, 2024) These medications mimic the actions of a hormone naturally found in the intestines, glucagon-like peptide-1 (GLP-1), which regulates blood sugar levels by increasing insulin secretion and decreasing glucagon release
Bulk-forming laxatives can be used more regularly, while stimulant laxatives should be used sparingly
cruzi growth, metacyclogenesis (Cardoso et al., 1996)
Semaglutide, the much-acclaimed key ingredient in weight loss drugs Wegovy, Ozempic and Rybelsus, has been shown to deliver benefits that last up to four years and, on average, result in a weight reduction of 10 percent compared to placebos
Peak effects occur within 30 to 90 minutes
When levels remain persistently elevated particularly without supplement use further assessment may be recommended to look for an underlying cause
